Intest Res.  2019 Apr;17(2):237-243. 10.5217/ir.2018.00071.

Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children's immunity

Affiliations
  • 1Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea. jassa@ewha.ac.kr
  • 2Department of Gastroenterology, University of Ulsan College of Medicine, Seoul, Korea.
  • 3Department of Pediatrics, Ewha Womans University School of Medicine, Seoul, Korea.
  • 4Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
  • 5Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Abstract

BACKGROUND/AIMS
The onset of inflammatory bowel disease (IBD) usually occurs at young age, and therefore, women IBD patients experience pregnancy during their disease progression. Recently, the use of anti-tumor necrosis factor-α (anti-TNF-α) has been rapidly increasing. The aim of this study was to evaluate pregnancy related outcomes in women with IBD who were treated with anti-TNF-α during pregnancy and immunity of their children.
METHODS
Korean women with IBD who had been treated with anti-TNF-α during pregnancy had been enrolled. Medical records were reviewed and a survey was performed for each patient. For the patients who agreed on additional examination for their children, children's growth, medical history and antibody to hepatitis B surface antigen (anti-HBs) titer were checked.
RESULTS
All 18 patients had been diagnosed with Crohn's disease. There was not any case of preterm delivery, low birth-weight infant, congenital anomaly, nor stillbirth. All 12 children had followed the regular vaccination schedule for hepatitis B and 4 of them showed negative results for anti-HBs. After the 1 booster vaccination, all children demonstrated seroconversion. Regarding live vaccines, 4 children had bacillus Calmette-Guerin and 4 had rotavirus vaccine before 6 months, without any specific side effects.
CONCLUSIONS
This was the first study of immunity of the children born from IBD women who had been treated with anti-TNF-α medication during their pregnancy. IBD women had comparable pregnancy outcomes with the general women population, suggesting that the disease activity rather than the administered medication would be more important in healthy pregnancy. Considering the history of vaccination and anti-HBs titers, immunity seems to be intact in the children.

Keyword

Inflammatory bowel disease; Anti-tumor necrosis factor alpha; Pregnancy outcome; Immunity; Anti-HBs antibody

MeSH Terms

Appointments and Schedules
Bacillus
Child
Crohn Disease
Disease Progression
Female
Hepatitis B
Hepatitis B Surface Antigens
Humans
Infant
Inflammatory Bowel Diseases*
Medical Records
Necrosis*
Pregnancy
Pregnancy Outcome
Rotavirus
Seroconversion
Stillbirth
Vaccination
Vaccines
Hepatitis B Surface Antigens
Vaccines
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr